83 related articles for article (PubMed ID: 16373886)
1. Cellular and molecular pathobiology of pulmonary hypertension conference summary.
Rabinovitch M
Chest; 2005 Dec; 128(6 Suppl):642S-646S. PubMed ID: 16373886
[No Abstract] [Full Text] [Related]
2. Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications.
Michelakis ED
Circ Res; 2006 Feb; 98(2):172-5. PubMed ID: 16456109
[No Abstract] [Full Text] [Related]
3. Pathobiology of pulmonary hypertension.
Rabinovitch M
Annu Rev Pathol; 2007; 2():369-99. PubMed ID: 18039104
[TBL] [Abstract][Full Text] [Related]
4. Pathology of pulmonary hypertension.
Tuder RM; Marecki JC; Richter A; Fijalkowska I; Flores S
Clin Chest Med; 2007 Mar; 28(1):23-42, vii. PubMed ID: 17338926
[TBL] [Abstract][Full Text] [Related]
5. Suppression of type II bone morphogenic protein receptor in vascular smooth muscle induces pulmonary arterial hypertension in transgenic mice.
West J; Tada Y; Fagan KA; Steudel W; Fouty BW; Harral JW; Miller M; Ozimek J; Tuder RM; Rodman DM
Chest; 2005 Dec; 128(6 Suppl):553S. PubMed ID: 16373822
[No Abstract] [Full Text] [Related]
6. Pulmonary arterial hypertension: a look to the future.
Rubin LJ; Galiè N
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):89S-90S. PubMed ID: 15194184
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
8. Severe pulmonary arterial hypertension: a forme fruste of cancer?
Humbert M; Hoeper MM
Am J Respir Crit Care Med; 2008 Sep; 178(6):551-2. PubMed ID: 18755928
[No Abstract] [Full Text] [Related]
9. [Primary pulmonary hypertension].
Otsuka F; Makino H
Nihon Rinsho; 2005 Oct; 63 Suppl 10():450-7. PubMed ID: 16279681
[No Abstract] [Full Text] [Related]
10. Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children.
Hall S; Brogan P; Haworth SG; Klein N
Thorax; 2009 Sep; 64(9):778-83. PubMed ID: 19525266
[TBL] [Abstract][Full Text] [Related]
11. Seeking the right targets: gene therapy advances in pulmonary arterial hypertension.
Machado RD
Eur Respir J; 2012 Feb; 39(2):235-7. PubMed ID: 22298609
[No Abstract] [Full Text] [Related]
12. Pathology and pathobiology of pulmonary hypertension.
Guignabert C; Dorfmuller P
Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
14. Primary pulmonary hypertension: molecular basis and potential for therapy.
Rudarakanchana N; Morrell NW
Expert Rev Mol Med; 2004 Mar; 6(6):1-15. PubMed ID: 15005857
[TBL] [Abstract][Full Text] [Related]
15. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
[TBL] [Abstract][Full Text] [Related]
16. BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report.
Handa T; Okano Y; Nakanishi N; Morisaki T; Morisaki H; Mishima M
Respir Investig; 2014 May; 52(3):195-8. PubMed ID: 24853021
[TBL] [Abstract][Full Text] [Related]
17. Hypertension: A new therapeutic strategy for PAH.
Carney EF
Nat Rev Nephrol; 2015 Aug; 11(8):445. PubMed ID: 26122732
[No Abstract] [Full Text] [Related]
18. Update in pulmonary arterial hypertension 2007.
Humbert M
Am J Respir Crit Care Med; 2008 Mar; 177(6):574-9. PubMed ID: 18316769
[No Abstract] [Full Text] [Related]
19. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
20. Pathology and Pathobiology of Pulmonary Hypertension.
Guignabert C; Dorfmüller P
Semin Respir Crit Care Med; 2017 Oct; 38(5):571-584. PubMed ID: 29032561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
